CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

Wanghong Hu, Zhenguo Zi, Yanling Jin, Gaoxin Li, Kang Shao, Qiliang Cai, Xiaojing Ma, Fang Wei

Cancer Immunology Immunotherapy · 2018 · 261 citations · 30 references

DOIFull text

Open access

Concepts

References

30